At WuXi AppTec, Partnerships Expedite Drug Development And Approvals: Interview With Dr. Hua Mu

WuXi AppTec considers partnerships a part of its overall product development capability, Dr. Hua Mu, SVP at WuXi told ChinaBio® Today in an exclusive interview. WuXi forms partnerships to advance product development for the partners and gain faster approval of the products in development for China, he said. The ChinaBio® Partnering Forum, which will be held May15-16 in Suzhou has been important to WuXi and Dr. Mu. When he returned to China six years ago, he met colleagues from Lilly at a ChinaBio Partnering Forum. Since then, he has formed two partnerships with Lilly.